Optimizing Treatment Selection in Advanced Renal Cell Carcinoma via IMDC Risk Group Stratification

Eur Urol. 2023 Oct;84(4):379-380. doi: 10.1016/j.eururo.2023.06.025. Epub 2023 Jul 14.

Authors

Amanda E Hird¹, Julián Chavarriaga¹, Aly-Khan A Lalani², Christopher J D Wallis³

Affiliations

¹ Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada.
² Division of Medical Oncology and Hematology, Juravinski Cancer Center, McMaster University, Hamilton, Canada.
³ Division of Urology, Department of Surgery, University of Toronto, Toronto, Canada. Electronic address: wallis.cjd@gmail.com.

PMID: 37455176
DOI: 10.1016/j.eururo.2023.06.025

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Renal Cell* / pathology
Humans
Kidney Neoplasms* / pathology
Retrospective Studies
Risk Factors